20 studies found for:    NIAID | Open Studies | Exclude Unknown | tuberculosis
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Training Protocol on the Natural History of Tuberculosis
Condition: Tuberculosis
Intervention:
2 Recruiting Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Conditions: Tuberculosis;   Filariasis
Intervention:
3 Not yet recruiting NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Moxifloxacin;   Drug: Pyrazindamide;   Drug: Rifampicin;   Drug: Isonizaid
4 Recruiting Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance
Condition: Tuberculosis
Intervention:
5 Recruiting Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
Condition: Latent Tuberculosis Infection
Intervention:
6 Recruiting DNA Sequencing of MDR TB in Eastern Siberia
Conditions: Tuberculosis;   HIV
Intervention:
7 Not yet recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Bedaquiline;   Drug: Delamanid;   Drug: Dolutegravir
8 Not yet recruiting Evaluating the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-Infected and HIV-1-Uninfected Pregnant and Postpartum Women With Latent Tuberculosis Infection
Condition: Tuberculosis
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (vitamin B6)
9 Recruiting Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects
Condition: Tuberculosis
Interventions: Other: AP10-602;   Biological: ID93;   Biological: GLA-SE
10 Recruiting Challenge Model for Assessment of Human TB Immunity
Condition: Tuberculosis
Intervention: Biological: BCG TICE strain
11 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
12 Recruiting Rewards for Tuberculosis Contact Screening
Conditions: Tuberculosis;   Drug-resistant Tuberculosis
Interventions: Behavioral: Contacts;   Behavioral: Index
13 Recruiting Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)
Condition: Tuberculosis
Interventions: Behavioral: Community-based intervention;   Other: Standard of care
14 Recruiting Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Raltegravir;   Drug: Isoniazid;   Drug: Pyridoxine;   Drug: Pyrazinamide;   Drug: Ethambutol;   Drug: Rifabutin;   Drug: Rifampin
15 Recruiting High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)
Condition: Tuberculosis
Interventions: Drug: Isoniazid;   Dietary Supplement: Vitamin B6
16 Recruiting Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa
Conditions: Latent Tuberculosis;   HIV
Intervention: Device: QGIT
17 Recruiting PK Study of Rifampicin Interactions With DMPA and Efaviranz in TB
Conditions: HIV-1 Infection;   Tuberculosis
Intervention: Drug: depot medroxyprogesterone acetate
18 Recruiting Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB
Condition: Tuberculosis, Multidrug-Resistant
Interventions: Drug: Levofloxacin;   Drug: Optimized background regimen (OBR)
19 Recruiting Test and Treat TB: A Proof of Concept Trial in South Africa
Condition: Tuberculosis
Intervention: Other: Test-and-Treat TB
20 Recruiting A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
Conditions: MDR-TB;   HIV
Intervention: Other: NCM-Plus

Indicates status has not been verified in more than two years